Instituto Rosenbusch S.A. Cash Flow Conversion Efficiency
Instituto Rosenbusch S.A. cash flow conversion efficiency. Based on the latest financial reports, Instituto Rosenbusch S.A. (ROSE) has a cash flow conversion efficiency ratio of -1.542x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AR$811.18 Million ≈ $586.98K USD) by net assets (AR$-526.19 Million ≈ $-380.75K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Instituto Rosenbusch S.A. stock valuation for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Instituto Rosenbusch S.A. (2000–2025)
Cash flow conversion efficiency of Instituto Rosenbusch S.A. from 2000 to 2025. This chart illustrates how Instituto Rosenbusch S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Instituto Rosenbusch S.A. for real-time trading data and today's change.
Instituto Rosenbusch S.A. Cash Flow Conversion Ratio Explained
Instituto Rosenbusch S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Instituto Rosenbusch S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Instituto Rosenbusch S.A. ranked by their cash flow conversion efficiency. Review Instituto Rosenbusch S.A. free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Brüder Mannesmann Aktiengesellschaft
F:BMM
|
-0.171x |
|
Traka Resources Ltd
AU:TKL
|
6.791x |
|
Bang Overseas Limited
NSE:BANG
|
-0.049x |
|
Sungshin Cement Co Ltd
KO:004985
|
0.075x |
|
Invibes Advertising NV
PA:ALINV
|
-0.215x |
|
CASI Pharmaceuticals Inc
NASDAQ:CASI
|
0.029x |
|
Openlearning Ltd
AU:OLL
|
0.356x |
|
FIXEDzone as
PR:FIXED
|
N/A |
Annual Cash Flow Conversion Efficiency for Instituto Rosenbusch S.A. (2000–2025)
The table below shows the annual cash flow conversion efficiency of Instituto Rosenbusch S.A. from 2000 to 2025. Also see total assets of Instituto Rosenbusch S.A. for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | AR$-526.19 Million ≈ $-380.75K |
AR$409.89 Million ≈ $296.60K |
-0.779x | -531.50% |
| 2024-12-31 | AR$3.99 Billion ≈ $2.89 Million |
AR$720.31 Million ≈ $521.22K |
0.181x | +147.75% |
| 2023-12-31 | AR$4.55 Billion ≈ $3.29 Million |
AR$331.37 Million ≈ $239.78K |
0.073x | -40.74% |
| 2022-12-31 | AR$400.51 Million ≈ $289.81K |
AR$49.25 Million ≈ $35.64K |
0.123x | -58.04% |
| 2021-12-31 | AR$199.19 Million ≈ $144.13K |
AR$58.37 Million ≈ $42.24K |
0.293x | -34.20% |
| 2020-12-31 | AR$147.69 Million ≈ $106.87K |
AR$65.78 Million ≈ $47.60K |
0.445x | -13.10% |
| 2019-12-31 | AR$115.52 Million ≈ $83.59K |
AR$59.20 Million ≈ $42.84K |
0.513x | +439.11% |
| 2018-12-31 | AR$145.95 Million ≈ $105.61K |
AR$-22.06 Million ≈ $-15.96K |
-0.151x | -272.55% |
| 2017-12-31 | AR$86.58 Million ≈ $62.65K |
AR$-3.51 Million ≈ $-2.54K |
-0.041x | -121.32% |
| 2016-12-31 | AR$83.24 Million ≈ $60.23K |
AR$15.84 Million ≈ $11.46K |
0.190x | +252.20% |
| 2015-12-31 | AR$70.62 Million ≈ $51.10K |
AR$-8.83 Million ≈ $-6.39K |
-0.125x | -192.60% |
| 2014-12-31 | AR$68.24 Million ≈ $49.38K |
AR$9.21 Million ≈ $6.67K |
0.135x | -32.36% |
| 2011-12-31 | AR$56.25 Million ≈ $40.70K |
AR$11.23 Million ≈ $8.12K |
0.200x | +96.02% |
| 2010-12-31 | AR$50.20 Million ≈ $36.32K |
AR$5.11 Million ≈ $3.70K |
0.102x | +352.72% |
| 2009-12-31 | AR$46.95 Million ≈ $33.97K |
AR$1.06 Million ≈ $764.13 |
0.022x | -87.71% |
| 2008-12-31 | AR$45.65 Million ≈ $33.03K |
AR$8.36 Million ≈ $6.05K |
0.183x | +811.58% |
| 2007-12-31 | AR$37.50 Million ≈ $27.13K |
AR$753.00K ≈ $544.87 |
0.020x | -65.96% |
| 2006-12-31 | AR$35.97 Million ≈ $26.03K |
AR$2.12 Million ≈ $1.54K |
0.059x | -61.58% |
| 2005-12-31 | AR$34.13 Million ≈ $24.70K |
AR$5.24 Million ≈ $3.79K |
0.154x | -9.98% |
| 2003-12-31 | AR$28.27 Million ≈ $20.45K |
AR$4.82 Million ≈ $3.49K |
0.171x | +122.37% |
| 2002-12-31 | AR$24.17 Million ≈ $17.49K |
AR$1.85 Million ≈ $1.34K |
0.077x | +268.10% |
| 2000-12-31 | AR$11.90 Million ≈ $8.61K |
AR$248.00K ≈ $179.45 |
0.021x | -- |
About Instituto Rosenbusch S.A.
Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious kera… Read more